Follow

Books from 2024

PDF

A Meta-Analysis of Models for Predicting the Incidence of Brain Metastasis in Lung Cancer Patients, Sufal Chhabra, Jung Ah Shin, Yanija Zhang, Md Ashfaq Ahmed, Zhenwei Zhang, Atulya Khosla, Mukesh Roy, Venkataraghavan Ramamoorthy, Muni Rubens, and Anshul Saxena

PDF

Lung Cancer Screening Adherence: An Integrative Review, Miri Sinclair

Submissions from 2023

Concurrent Administration of Immune Checkpoint Inhibitors and Single Fraction Stereotactic Radiosurgery in Patients With Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma Brain Metastases, Manmeet Ahluwalia

A Randomized Study of Low-Intensity Focused Ultrasound for Blood-Brain Barrier Disruption for Brain Metastasis from Non-Small Cell Lung Cancer (LIMITLESS), Manmeet Ahluwalia, Michael McDermott, Ahmad Ozair, and Atulya Khosla

Prophylactic Cranial Irradiation in Small Cell Lung Cancer Patients in the Era of Magnetic Resonance Imaging: A Systematic Review and Meta-analysis, Manmeet Ahluwalia and Minesh Mehta

Enhancing lung cancer screening through ‘Saved by the Scan’: Lessons from a multipronged public service advertising program., Shreyas Bellur, Ahmad Ozair, Atulya Khosla, Juan Batlle, Mark Dylewski, and Manmeet Ahluwalia

Immune checkpoint inhibition and single fraction stereotactic radiosurgery in brain metastases from non-small cell lung cancer: an international multicenter study of 395 patients, Atulya Khosla, Ahmad Ozair, and Manmeet Ahluwalia

Phase I Dose Escalation Trial Combining Olaparib and Thoracic Radiation Therapy in Extensive-Stage Small Cell Lung Cancer, Rupesh Kotecha

Tumor Treating Fields (TTFields) therapy with standard of care (SOC) systemic therapy in advanced non-small cell lung cancer (aNSCLC) following platinum failure: Final results of the phase 3, randomized LUNAR study, Rupesh Kotecha

PDF

Accelerated hypofractionated magnetic resonance-guided adaptive radiotherapy for oligoprogressive non-small cell lung cancer, Alonso La Rosa de los Rios, Kathryn Mittauer, Michael Chuong, Matthew Hall, Tugce Kutuk, Nema Bassiri-Gharb, James McCulloch, Diane Alvarez, Raul Herrera, Alonso Gutierrez, Ranjini Tolakanahalli, Minesh Mehta, and Rupesh Kotecha

PDF

First- versus Third-Generation EGFR Tyrosine Kinase Inhibitors in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases, Ahmad Ozair, Atulya Khosla, Shreya Saxena, and Manmeet Ahluwalia

Treatment of Oligometastatic Non-Small Cell Lung Cancer: An ASTRO/ESTRO Clinical Practice Guideline, Hina Saeed

PDF

Combination of EGFR-Directed Tyrosine Kinase Inhibitors (EGFR-TKI) with Radiotherapy in Brain Metastases from Non-Small Cell Lung Cancer: A 2010-2019 Retrospective Cohort Study, Shreya Saxena, Atulya Khosla, Ahmad Ozair, Rupesh Kotecha, and Manmeet Ahluwalia

PDF

Combination of EGFR-Directed Tyrosine Kinase Inhibitors (EGFR-TKI) with Radiotherapy in Brain Metastases from Non-Small Cell Lung Cancer: A 2010-2019 Retrospective Cohort Study, Shreya Saxena, Atulya Khosla, Ahmad Ozair, Rupesh Kotecha, and Manmeet Ahluwalia

Submissions from 2022

PDF

Author Correction: Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases, Manmeet Ahluwalia

Phase II Trial of Concurrent Durvalumab and Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer: A Pre-Planned Interim Analysis, Federico Albrecht, Rupesh Kotecha, and Zhenwei Zhang

PDF

Phase I Study of Accelerated Hypofractionated Proton Therapy and Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer, Jessika Contreras

Keynote B36: Open-label study of first-line tumor treating fields (150kHz) plus pembrolizumab for non-small cell lung cancer, Rupesh Kotecha

Predicting pulmonary toxicities from proton radiotherapy in locally advanced lung cancer patients enrolled on the Proton Collaborative Group clinical trial NCT01255748, Rupesh Kotecha

PDF

Author Correction: Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases, Rupesh Kotecha and Manmeet Ahluwalia

Phase I Dose Escalation Trial Combining Olaparib and Thoracic Radiation Therapy in Extensive-Stage Small Cell Lung Cancer, Rupesh Kotecha and Federico Albrecht

PDF

Volume doubling time and radiomic features predict tumor behavior of screen-detected lung cancers, Tugce Kutuk

The Graded Prognostic Assessment (GPA) for Lung Cancer Patients with Brain Metastases: Initial Report of the Small Cell Lung Cancer GPA and Update of the Non-Small Cell Lung Cancer GPA including the Effect of Programmed Death Ligand-1 (PD-L1) and Other Prognostic Factors, Tugce Kutuk, Rupesh Kotecha, Manmeet Ahluwalia, and Minesh Mehta

Role of Radiotherapy in Brain Metastases from Lung Cancer, Minesh Mehta

Pralsetinib (Gavreto): Treatment of metastatic non-small-cell lung cancer in patients positive for RET fusions, Shanada Monestime

Pralsetinib: Treatment of metastatic RET fusion-positive non-small cell lung cancer, Shanada Monestime

PDF

Small spot size versus large spot size: Effect on plan quality for lung cancer in pencil beam scanning proton therapy, Suresh Rana

Clinical Outcomes for Plasma-Based Comprehensive Genomic Profiling Versus Standard-of-Care Tissue Testing in Advanced Non-Small Cell Lung Cancer, Miguel Villalona Calero

Submissions from 2021

PDF

Author Correction: Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases, Manmeet Ahluwalia

PDF

Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases, Manmeet Ahluwalia

PDF

Predictors of attrition in a smoking cessation trial conducted in the lung cancer screening setting, Juan Batlle

PDF

Bone Metastases in Lung Cancer, Ana Cecilia Belzarena Genovese

PDF

Case report of visual biofeedback-driven, magnetic resonance-guided single-fraction SABR in breath hold for early stage non-small-cell lung cancer, Michael Chuong, Rupesh Kotecha, Minesh Mehta, Sonia Adamson, Tino Romaguera, Matthew Hall, Diane Alvarez, Alonso Gutierrez, Vivek Mishra, Fernando De Zarraga, and Kathryn Mittauer

PDF

Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases, Rupesh Kotecha and Manmeet Ahluwalia

PDF

Investigating volumetric repainting to mitigate interplay effect on 4D robustly optimized lung cancer plans in pencil beam scanning proton therapy, Suresh Rana

Systematic review and meta-analysis of lung cancer brain metastasis and primary tumor receptor expression discordance, Raees Tonse, Muni Rubens, Haley Appel, Martin Tom, Matthew Hall, Yazmin Odia, Michael McDermott, Manmeet Ahluwalia, Minesh Mehta, and Rupesh Kotecha

PDF

Systematic review and meta-analysis of PD-L1 expression discordance between primary tumor and lung cancer brain metastasis, Raees Tonse, Muni Rubens, Haley Appel, Martin Tom, Matthew Hall, Yazmin Odia, Michael McDermott, Manmeet Ahluwalia, Minesh Mehta, and Rupesh Kotecha

PDF

OTHR-07. Systematic Review and Meta-analysis of Lung Cancer Brain Metastasis and Primary Tumor PD-L1 Expression Discordance, Raees Tonse, Muni Rubens, Haley Appel, Martin Tom, Matthew Hall, Yazmin Odia, Minesh Mehta, Michael McDermott, manmeet Ahluwalia, and Rupesh Kotecha

Systemic Therapy and Radiation Therapy in Lung Cancer, Raees Tonse, Martin Tom, and Rupesh Kotecha

Submissions from 2020

PDF

The Association Between Laboratory Pretreatment Immune Parameters and Radiographic Lung Changes in Early Stage Lung Cancer Patients Undergoing Stereotactic Body Radiation Therapy, Noah Kalman

PDF

Brain metastases from non-small cell lung cancer with EGFR or ALK mutations: A systematic review and meta-analysis of multidisciplinary approaches, Rupesh Kotecha

CTIM-22. PHASE 1 TRIAL OF OSIMERTINIB WITH STEREOTACTIC RADIOSURGERY (SRS) IN PATIENTS WITH BRAIN METASTASES FROM EGFR POSITIVE NON-SMALL-CELL LUNG CANCER (NSCLC), Rupesh Kotecha

PDF

A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Newly Diagnosed Stage IV Squamous Cell Lung Cancers, Miguel Villalona Calero

Submissions from 2019

PDF

Study protocol for a telephone-based smoking cessation randomized controlled trial in the lung cancer screening setting: The lung screening, tobacco, and health trial, Juan Batlle

PDF

Management of patients with brain metastases from non-small cell lung cancer and adverse prognostic features: multi-national radiation treatment recommendations are heterogeneous, Minesh Mehta

PDF

Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non-small Cell Lung Cancer, Miguel Villalona Calero

Submissions from 2018

A five-step strategy for building an LDCT lung cancer screening program, Juan Batlle, Muhammad Latif, and Ricardo Cury

PDF

Robotic resection of Stage III lung cancer: an international retrospective study, Mark Dylewski

PDF

The long-term survival of robotic lobectomy for non-small cell lung cancer: A multi-institutional study, Mark Dylewski

PDF

Brain Metastases in Lung Cancer With Targetable Mutations-Reply, Minesh Mehta

PDF

Adaptive planning and toxicities of uniform scanning proton therapy for lung cancer patients, Suresh Rana

PDF

Incidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With Non-Small-cell Lung Cancer, Miguel Villalona Calero

Submissions from 2017

PDF

Robotic assisted lobectomy for locally advanced lung cancer, Mark Dylewski

PDF

Cost-effectiveness of prophylactic cranial irradiation with hippocampal avoidance in limited stage small cell lung cancer, Minesh Mehta

PDF

Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Stage I Small Cell Lung Cancer, Minesh Mehta

PDF

Reirradiation of recurrent node-positive non-small cell lung cancer after previous stereotactic radiotherapy for stage I disease : A multi-institutional treatment recommendation, Minesh Mehta